Title |
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
|
---|---|
Published in |
Trials, July 2020
|
DOI | 10.1186/s13063-020-04576-9 |
Pubmed ID | |
Authors |
Justin T. Denholm, Joshua Davis, David Paterson, Jason Roberts, Susan Morpeth, Thomas Snelling, Dominica Zentner, Megan Rees, Matthew O’Sullivan, David Price, Asha Bowen, Steven Y. C. Tong |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 50% |
United States | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 160 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 21 | 13% |
Student > Master | 18 | 11% |
Researcher | 14 | 9% |
Other | 12 | 8% |
Student > Ph. D. Student | 7 | 4% |
Other | 26 | 16% |
Unknown | 62 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 40 | 25% |
Nursing and Health Professions | 12 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 6% |
Biochemistry, Genetics and Molecular Biology | 7 | 4% |
Social Sciences | 6 | 4% |
Other | 22 | 14% |
Unknown | 63 | 39% |